Stand out for this role — generate a tailored resume and cover letter in about a minute.
Integra Connect, LLC is seeking a Medical QA Analyst (Oncology) with Software Engineer in Test (SEIT) experience to ensure quality, accuracy, and regulatory compliance of oncology-focused healthcare applications.
The role blends oncology domain knowledge with hands-on software QA, requiring collaboration with Product, Medical SMEs, Business Analysts, Engineering, and QA teams to translate requirements into test scenarios and ensure safe, reliable healthcare technology solutions.
We are a value-based, precision medicine company specializing in Health IT, real-world data, and digital health solutions for specialty providers, payers, and life sciences companies. Through the provision of technology products and technology-enabled services, along with unmatched clinical expertise, we are able to close gaps in care, improve patient outcomes, generate real-world evidence, and accelerate and augment customer commercial success across the healthcare value chain. We are looking for like-minded individuals committed to making a difference in healthcare. Come join our growing team!
We are seeking a Medical QA Analyst (Oncology) with Software Engineer in Test (SEIT) experience to support the quality, accuracy, and compliance of oncology-focused healthcare applications.
This role combines oncology domain knowledge with hands-on software quality assurance. The ideal candidate understands oncology workflows, medication management, clinical documentation, and patient care processes and can translate that knowledge into effective software testing strategies.
You will work with Product, Medical SMEs, Business Analysts, Engineering, and QA teams to translate requirements into test scenarios, identify defects, validate functionality, and help deliver safe, reliable healthcare technology solutions.
Integra Connect, LLC provides a comprehensive benefits plan
Equal Opportunity Employer
Please note that the deadline for submitting applications is September 30, 2026. All applications must be received by this date to be considered.